Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 553-564 of 4,306
Drug study icon
WithdrawnNCT05956600

An Single-Arm study Evaluating the Safety and Efficacy of Amisulpride in Treating people with Schizophrenia and Schizoaffective Disorder Who Have Treatment-Resistant Positive Symptoms

This study was withdrawn. It focuses on schizophrenia.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
Sponsor
University of California, Los Angeles
Condition
Schizophrenia
Drug study icon
CompletedNCT04779177

Safety study of lumateperone in schizophrenia

This study is completed in the United States. It is testing lumateperone for schizophrenia.

Multiple locations, including Hollywood
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 13 Years to 17 Years
Countries
United States
Sponsor
Intra-Cellular Therapies, Inc.
Condition
Schizophrenia
Other study type icon
CompletedNCT07043803

Reduction of Anticholinergic Medications Among Persons With Schizophrenia or Other Psychiatric Disorders

This study is looking at whether a digital support tool can help people with Schizophenia Disorder, schizoaffective disorder, or bipolarity. Participants receive a study treatment and complete follow-up visits and assessments.

Multiple locations, including Altoona
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, BipolarityOtherOver 18 Years
Countries
United States
Sponsor
University of Pittsburgh
Condition
Schizophrenia, Bipolarity
Drug study icon
Not recruitingISRCTN68736636

The European First Episode Schizophrenia study (EUFEST): Comparison of outcome in first episode schizophrenia with different low dose antipsychotic drug regimens

This study is not recruiting in France, in Switzerland, in Belgium, .... It focuses on schizophrenia.

In Austria
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherOver 18 Years
Countries
France, Switzerland, Belgium, ...
Sponsor
European Group for Research in Schizophrenia (EGRIS) (Austria)
Condition
Schizophrenia
Drug study icon
Not recruitingISRCTN45593573

ATLAS: Antipsychotic Treatment of very LAte-onset Schizophrenia-like psychosis

This study is looking at care and outcomes for people with Late onset schizophrenia like psychosis, Mental and Behavioural Disorders, or Schizophrenia. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOther
Countries
United Kingdom
Sponsor
King’s College London (UK)
Condition
Schizophrenia
Drug study icon
CompletedNCT02006628

GWP42003 for schizophrenia

This study is completed in the United Kingdom, in Poland, and in Romania. It is testing GWP42003 for schizophrenia.

Multiple locations, including Czeladź
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United Kingdom, Poland, Romania
Sponsor
Jazz Pharmaceuticals
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.